Search Within

Michael David Offin

Formats
  1. Meeting Abstract (88)
  2. Journal Article (75)
  3. Editorial (4)
  4. Review (4)
  5. Conference Paper (1)
  6. Correspondence (1)
Groups
  1. Department of Medicine (173)
  2. Solid Tumor Oncology Division (173)
  3. Thoracic Oncology (173)
  4. Weinberg Fellows (173)
  5. Department of Pathology and Laboratory Medicine (113)
  6. GSK Faculty (111)

More Groups

People
  1. Charles Rudin (69)
  2. Marc Ladanyi (59)
  3. Mark Kris (57)
  4. Alexander Drilon (53)
  5. Bob Li (53)
  6. Marjorie Zauderer (45)

More People

Years
  1. 2025 (6)
  2. 2024 (23)
  3. 2023 (16)
  4. 2022 (25)
  5. 2021 (34)
  6. 2020 (20)

More Years

Publications
  1. Journal of Thoracic Oncology (32)
  2. Journal of Clinical Oncology (29)
  3. Clinical Cancer Research (12)
  4. International Journal of Radiation Oncology, Biology, Physics (12)
  5. Annals of Oncology (8)
  6. Modern Pathology (8)

More Publications

Publishers
  1. Elsevier Inc. (52)
  2. American Society of Clinical Oncology (37)
  3. American Association for Cancer Research (21)
  4. Oxford University Press (14)
  5. Nature Publishing Group (9)
  6. Nature Research (8)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A safety study of avelumab plus SBRT in malignant mesothelioma
    Meeting Abstract

    Rimner, A.; Yorke, E.; Gelblum, D.; Shepherd, A.; Guttmann, D.; Iqbal, A.; Daly, R.; Offin, M.; Fiore, J.; Namakydoust, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Allele-specific role of ERBB2 in the oncogenic function of EGFR L861Q in EGFR-mutant lung cancers
    Journal Article

    Sato, H.; Offin, M.; Kubota, D.; Yu, H. A.; Wilhelm, C.; Toyooka, S.; Somwar, R.; Kris, M. G.; Ladanyi, M.
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Clinical and dosimetric predictors of radiation pneumonitis in patients with non-small cell lung cancer undergoing postoperative radiation therapy
    Journal Article

    Shepherd, A. F.; Iocolano, M.; Leeman, J.; Imber, B. S.; Wild, A. T.; Offin, M.; Chaft, J. E.; Huang, J.; Rimner, A.; Wu, A. J.; more...
    Practical Radiation Oncology (2021)

    Fulltext@MSK | Save
  • Locoregional control, failure patterns and clinical outcomes in patients with stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Meeting Abstract

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A.; Simone, C. B.; Gelblum, D. Y.; Wu, A. J. C.; Lee, N. Y.; Kris, M. G.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The utility of plasma ctDNA for detection of KRAS G12C and other mutations in lung cancers
    Meeting Abstract

    Murciano-Goroff, Y. R.; Arbour, K. C.; Offin, M. D.; Tu, H. Y. Y.; Lebow, E. S.; Shaffer, T. S.; Bertucci, C.; Hosseini, S. A.; Garg, K.; Lim, L. P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors
    Journal Article

    Shaverdian, N.; Beattie, J.; Thor, M.; Offin, M.; Shepherd, A. F.; Gelblum, D. Y.; Wu, A. J.; Simone, C. B. 2nd; Hellmann, M. D.; Chaft, J. E.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Durvalumab with concurrent definitive radiation therapy (DART) for locally-advanced non-small cell lung cancer: A phase II study
    Meeting Abstract

    Rimner, A.; Offin, M.; Shaverdian, N.; McKnight, D.; Li, H.; McCune, M.; Patson, B.; Kotecha, R.; Gomez, D. R.; Chaft, J.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Exploring associations between immune parameters and radiation pneumonitis in locally advanced non-small cell lung cancer after chemoradiation and durvalumab
    Meeting Abstract

    Thor, M.; Shaverdian, N.; Shepherd, A. F.; Offin, M.; Jackson, A.; Wu, A. J.; Gelblum, D.; Yorke, E. D.; Simone, C. B. 2nd; Gomez, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save